CCAMP

C-CAMP receives CSR support from Cytiva to foster early-stage innovations in India

by
C-CAMP receives CSR support from Cytiva to foster early-stage innovations in India

Taslimarif Saiyed, CEO and Director, Centre for Cellular and Molecular Platforms (C-CAMP) Centre for Cellular and Molecular Platforms (C-CAMP) has received Corporate Social Responsibility (CSR) funding from global biotech giant Cytiva to support early-stage start-ups in India. Bengaluru-based C-CAMP is an initiative supported by government of India. C-CAMP has directly funded, incubated and mentored 350-plus … Read more

C-CAMP launches Antimicrobial Resistance Quest

by
C-CAMP launches Antimicrobial Resistance Quest

The Centre for Cellular and Molecular Platforms (C-CAMP) is launching the 4th edition of Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) supported Antimicrobial Resistance (AMR) Quest. The Quest is a nationwide platform dedicated exclusively to innovations in the AMR domain and aims to identify, reward, and nurture Indian innovators developing solutions to tackle AMR with a … Read more

C-CAMP collaborates with Swiss organisation to tackle resistant bacterial infections 

by
C-CAMP collaborates with Swiss organisation to tackle resistant bacterial infections 

The letter of intent being signed by Taslimarif Saiyed, CEO-Director of C-CAMP, François Franceschi, Head of Asset Evaluation and Development at GARDP, and Subasree Srinivasan, GARDP Medical Director. The Centre for Cellular and Molecular Platforms (C-CAMP) has joined hands with a Swiss not-for-profit organization, Global Antibiotic Research and Development Partnership (GARDP), to tackle the global … Read more